Article Text

PDF
Time to consider a targeted HPV vaccination programme for male military recruits
  1. William M J Sharp1,
  2. T Nadarzynski2,3 and
  3. N E Dufty4,5
  1. 1DPMO, Medical Centre, RNAS Yeovilton, Yeovil, UK
  2. 2Department of Sexual Health Services, Solent NHS Trust, Southampton, UK
  3. 3Department of Psychology, University of Southampton, Southampton, UK
  4. 4Department of Sexual Health, Birmingham Heartlands Hospital, Birmingham, UK
  5. 5Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, UK
  1. Correspondence to William M J Sharp, DPMO, Medical Centre, RNAS Yeovilton, Yeovil BA22 8HT, UK; willsharp{at}hotmail.co.uk

Abstract

Human papillomaviruses (HPV) are the most common type of sexually transmitted infection in men but also related to high-risk cancers. This article considers the epidemiology of HPV in the male military population, the UK vaccination programme and the current UK Joint Committee on Vaccination and Immunisation recommendations. Military men may not benefit from HPV herd immunity and may have a different risk profile; vaccination may in turn reduce the operational burden of HPV-related disease within this population. Military men may benefit from a targeted vaccination programme, and the paper calls for urgent consideration of approaches that could protect them from acquiring HPV.

  • Infectious Diseases
  • Sexual Medicine
  • Epidemiology
  • Public Health
  • Primary Care

Statistics from Altmetric.com

Footnotes

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.